VEGFA and metastatic malignant neoplasm: In this series, the median platelet VEGF concentration, estimated from the ratio between serum VEGF and platelet count, was 1.5 pg 10−6 platelets, which is in agreement with results obtained in other series of metastatic cancer patients (Salgado et al, 1999; Salven et al, 1999a).